AzTrials
AzTrials

Body Weight ChangesNCT03602144

Breakfast and Muscle Health in Children

A study testing Carbohydrate and Protein in people with Body Weight Changes and Body Composition, run by University of Arkansas, Fayetteville at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

One in every three children ages 2-19 years is overweight or obese. Although multifactorial in nature, obesity is primarily attributed to a mismatch between energy intake and energy expenditure (EE). Read more about this study

Who is it for?
Ages 7 to 14 yearsHealthy volunteers can take part
Conditions the study is for
Body Weight Changes, Body Composition, Muscle Mass
What is being tested?
Carbohydrate and Protein
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteUnited States
Study dates
21 Jun 2018to 31 Aug 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Resides within Northwest Arkansas
  • Age 8-12 years old
  • BMI >5th percentile
  • All ethnicities

Who cannot join

  • Food allergies
  • Dietary restrictions
  • Regularly skip breakfast (> 5 times per week)
  • Prescription medications
  • Claustrophobic
  • Fear of needles
  • Classified as a picky eater by parent/guardian

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Arkansas

    Fayetteville, Arkansas, 72704

Other trials in United States

About this study

Official title: Breakfast, Energy Metabolism, and Skeletal Muscle Health in Obese Children

One in every three children ages 2-19 years is overweight or obese. Although multifactorial in nature, obesity is primarily attributed to a mismatch between energy intake and energy expenditure (EE). Daily EE (DEE) can be partitioned between resting metabolic rate (RMR), EE associated with physical activity, and the thermic effect of food (TEF). RMR corresponds to the energy needed to sustain the body functions at rest and is also related to body composition (i.e., ratio of skeletal muscle mass to fat mass). Skeletal muscle mass is a large contributor to RMR; the more skeletal muscle mass, the higher the RMR (i.e., more energy expended at rest). In addition, muscle plays a central role in whole body protein metabolism and disrupted muscle metabolism is associated with the development of many common chronic diseases associated with obesity such as type 2 diabetes and cardiovascular disease. Although the contribution of disrupted muscle metabolism to chronic disease is well-established in older adults, the potential impact in children is unknown. The overall objective for this primary project application is to determine the role of breakfast protein consumption in improving energy metabolism, energy balance and skeletal muscle health in obese, school-aged children.

Being tested
Carbohydrate, Protein
Medical subject headings
Body Weight Changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CarbohydrateOther

    Participants will receive a carbohydrate-based breakfast beverage everyone morning for 42 days.

  • ProteinOther

    Participants will receive a protein-based breakfast beverage everyone morning for 42 days.

Study groups in NCT03602144
Study groupRoleWhat they receive
CarbohydrateActive comparatorParticipants will receive a carbohydrate-based smoothie every morning for 6 weeks (42 days).
Receives: Other: Carbohydrate
ProteinExperimentalParticipants will receive a protein-based smoothie every morning for 6 weeks (42 days).
Receives: Other: Protein

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Whole body energy expenditure (WBEE)

    WBEE will be measured using doubly labeled water.

    Measured: WBEE will be measured as the change between WBEE during day 1 and day 42 of the intervention.

Secondary outcomes (7)
  1. Appetite (VAS)

    Appetite response to test beverages will be measured using visual analog scales. Appetite and palatability were assessed using a traditional 100-mm visual analog scale (VAS) [33] with opposing anchors (e.g., "extremely hungry" or "not hungry at all") at time points 0, 15, 30, 60, 90, and 120 min. Questions consisted of: "how hungry do you feel at this moment", "how full do you feel at this moment", "how strong is your desire to eat this moment" and "how much food do you think you can eat at this moment". A higher number is associated with increased hunger.

    Measured: VAS will be measured on day 1 and day 42.

  2. Glycemic Response

    Glucose and insulin will be measured using commercially available kits.

    Measured: Glycemic response will be measured on day 1 and day 42.

  3. Muscle mass

    Muscle mass will be measured using stable isotope-labeled creatine.

    Measured: Change in muscle mass will be determined by the difference in muscle mass between day 1 and day 42.

  4. Muscle fractional synthesis rate (FSR)

    FSR will be measured using deuterated water and markers of muscle health in plasma.

    Measured: FSR will be determined as the change between baseline (day 0) and day 42.

  5. Whole body protein turnover (WPT)

    WPT will be measured via stable isotope-labeled nitrogen.

    Measured: Change in WPT will be determined by the difference in WPT between day 1 and day 42.

  6. Resting energy expenditure (REE)

    REE will be measured using indirect calorimetry.

    Measured: Change in REE will be determined by the difference in REE between day 1 and day 42.

  7. Body composition

    Body composition will be measured via dual x-ray absorptiometry.

    Measured: Change in body composition will be determined by the difference in body composition between day 1 and day 42.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2018
  2. Study start21 Jun 2018
  3. Primary completion15 Sep 2019
  4. Study completion31 Aug 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03602144
Sponsor's protocol ID
BEMS1
Status last verified
Feb 2021
First submitted
15 Jul 2018
Last updated
4 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Carbohydrate and Protein in people with Body Weight Changes and Body Composition, run by University of Arkansas, Fayetteville at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Whole body energy expenditure (WBEE) (time frame: WBEE will be measured as the change between WBEE during day 1 and day 42 of the intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in